334 related articles for article (PubMed ID: 10460196)
1. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice.
Zhou JR; Gugger ET; Tanaka T; Guo Y; Blackburn GL; Clinton SK
J Nutr; 1999 Sep; 129(9):1628-35. PubMed ID: 10460196
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of murine bladder tumorigenesis by soy isoflavones via alterations in the cell cycle, apoptosis, and angiogenesis.
Zhou JR; Mukherjee P; Gugger ET; Tanaka T; Blackburn GL; Clinton SK
Cancer Res; 1998 Nov; 58(22):5231-8. PubMed ID: 9823337
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of orthotopic growth and metastasis of androgen-sensitive human prostate tumors in mice by bioactive soybean components.
Zhou JR; Yu L; Zhong Y; Nassr RL; Franke AA; Gaston SM; Blackburn GL
Prostate; 2002 Oct; 53(2):143-53. PubMed ID: 12242729
[TBL] [Abstract][Full Text] [Related]
4. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis.
Singh AV; Franke AA; Blackburn GL; Zhou JR
Cancer Res; 2006 Feb; 66(3):1851-8. PubMed ID: 16452247
[TBL] [Abstract][Full Text] [Related]
5. Decreased growth of human prostate LNCaP tumors in SCID mice fed a low-fat, soy protein diet with isoflavones.
Aronson WJ; Tymchuk CN; Elashoff RM; McBride WH; McLean C; Wang H; Heber D
Nutr Cancer; 1999; 35(2):130-6. PubMed ID: 10693166
[TBL] [Abstract][Full Text] [Related]
6. Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice.
Zhou JR; Yu L; Mai Z; Blackburn GL
Int J Cancer; 2004 Jan; 108(1):8-14. PubMed ID: 14618609
[TBL] [Abstract][Full Text] [Related]
7. Alpha-tocopheryl succinate (alpha-TOS) modulates human prostate LNCaP xenograft growth and gene expression in BALB/c nude mice fed two levels of dietary soybean oil.
Basu A; Grossie B; Bennett M; Mills N; Imrhan V
Eur J Nutr; 2007 Feb; 46(1):34-43. PubMed ID: 17180484
[TBL] [Abstract][Full Text] [Related]
8. Soy phytochemicals synergistically enhance the preventive effect of tamoxifen on the growth of estrogen-dependent human breast carcinoma in mice.
Mai Z; Blackburn GL; Zhou JR
Carcinogenesis; 2007 Jun; 28(6):1217-23. PubMed ID: 17234721
[TBL] [Abstract][Full Text] [Related]
9. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
Guo Y; Wang S; Hoot DR; Clinton SK
J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
[TBL] [Abstract][Full Text] [Related]
10. Soy phytochemicals and tea bioactive components synergistically inhibit androgen-sensitive human prostate tumors in mice.
Zhou JR; Yu L; Zhong Y; Blackburn GL
J Nutr; 2003 Feb; 133(2):516-21. PubMed ID: 12566493
[TBL] [Abstract][Full Text] [Related]
11. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
12. Soy isoflavones alter expression of genes associated with cancer progression, including interleukin-8, in androgen-independent PC-3 human prostate cancer cells.
Handayani R; Rice L; Cui Y; Medrano TA; Samedi VG; Baker HV; Szabo NJ; Shiverick KT
J Nutr; 2006 Jan; 136(1):75-82. PubMed ID: 16365062
[TBL] [Abstract][Full Text] [Related]
13. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.
Hedlund TE; Johannes WU; Miller GJ
Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257
[TBL] [Abstract][Full Text] [Related]
14. Antitumor and antiangiogenic activity of soy phytoestrogen on 7,12-dimethylbenz[alpha]anthracene-induced mammary tumors following ovariectomy in Sprague-Dawley rats.
Kang X; Jin S; Zhang Q
J Food Sci; 2009 Sep; 74(7):H237-42. PubMed ID: 19895476
[TBL] [Abstract][Full Text] [Related]
15. Differential effects of whole soy extract and soy isoflavones on apoptosis in prostate cancer cells.
Hsu A; Bray TM; Helferich WG; Doerge DR; Ho E
Exp Biol Med (Maywood); 2010 Jan; 235(1):90-7. PubMed ID: 20404023
[TBL] [Abstract][Full Text] [Related]
16. Dietary genistein improves survival and reduces expression of osteopontin in the prostate of transgenic mice with prostatic adenocarcinoma (TRAMP).
Mentor-Marcel R; Lamartiniere CA; Eltoum IA; Greenberg NM; Elgavish A
J Nutr; 2005 May; 135(5):989-95. PubMed ID: 15867270
[TBL] [Abstract][Full Text] [Related]
17. Energy intake and prostate tumor growth, angiogenesis, and vascular endothelial growth factor expression.
Mukherjee P; Sotnikov AV; Mangian HJ; Zhou JR; Visek WJ; Clinton SK
J Natl Cancer Inst; 1999 Mar; 91(6):512-23. PubMed ID: 10088621
[TBL] [Abstract][Full Text] [Related]
18. The potential of soybean foods as a chemoprevention approach for human urinary tract cancer.
Su SJ; Yeh TM; Lei HY; Chow NH
Clin Cancer Res; 2000 Jan; 6(1):230-6. PubMed ID: 10656454
[TBL] [Abstract][Full Text] [Related]
19. Effects of soybean isoflavones on cell growth and apoptosis of the human prostatic cancer cell line LNCaP.
Onozawa M; Fukuda K; Ohtani M; Akaza H; Sugimura T; Wakabayashi K
Jpn J Clin Oncol; 1998 Jun; 28(6):360-3. PubMed ID: 9730149
[TBL] [Abstract][Full Text] [Related]
20. Soy protein extract (SPE) exhibits differential in vitro cell proliferation effects in oral cancer and normal cell lines.
Kingsley K; Truong K; Low E; Hill CK; Chokshi SB; Phipps D; West MA; Keiserman MA; Bergman CJ
J Diet Suppl; 2011 Jun; 8(2):169-88. PubMed ID: 22432688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
